Publications - Gulati Laboratory

Publications

2024

Poplausky D, Block BR, Chang A, Thakker S, Young JN, Gulati N, Ungar J. Single-institution retrospective review evaluating the impact of the Covid-19 pandemic on isotretinoin prescribing practices. J Dermatolog Treat. 2024 Dec;35(1):2291326. doi: 10.1080/09546634.2023.2291326. Epub 2023 Dec 15. PubMed PMID: 38102844.
Powers CM, Verma H, Orloff J, Piontkowski AJ, Tiersten A, Lamb A, Gulati N. Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report. J Dermatolog Treat. 2024 Dec;35(1):2336118. doi: 10.1080/09546634.2024.2336118. Epub 2024 Apr 2. PubMed PMID: 38565207.
Orloff J, Patel DD, Powers CM, Piontkowski AJ, Phelps RG, Richter J, Gulati N. Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab. JAAD Case Rep. 2024 May;47:23-25. doi: 10.1016/j.jdcr.2024.02.021. eCollection 2024 May. PubMed PMID: 38576898; PubMed Central PMCID: PMC10993135.
O’Hagan R, Ngandjui J, Ungar B, Ungar J, Gulati N. A Survey of Demographics and Treatments in Melanoma Case Reports: Retrospective Bibliometric Analysis. JMIR Dermatol. 2024 Apr 22;7:e56684. doi: 10.2196/56684. PubMed PMID: 38648085.
Brüggen MC, Traidl S, Mitamura Y, Walsh S, French LE, Gulati N, Phillips E, Maverakis E, Ingen-Housz-Oro S. Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients. Allergy. 2024 Apr 8;. doi: 10.1111/all.16122. [Epub ahead of print] PubMed PMID: 38587051.
Powers CM, Piontkowski AJ, Block BR, Orloff J, Guttman-Yassky E, Gulati N. Pemphigoid and atopy: A case-control study in the All of Us database. J Allergy Clin Immunol Pract. 2024 Apr 6;. doi: 10.1016/j.jaip.2024.04.005. [Epub ahead of print] PubMed PMID: 38588912.
Powers CM, Piontkowski AJ, Orloff J, Pulsinelli J, Uddin FB, Correa Da Rosa J, Ungar B, Gulati N. Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database. J Am Acad Dermatol. 2024 Apr 4;. doi: 10.1016/j.jaad.2024.03.038. [Epub ahead of print] PubMed PMID: 38582238.
Obi A, McKinley J, Oladunjoye E, Williams A, Li V, Wu J, Yang C, Darwin E, Gulati N, Haskin A, Correa da Rosa J, Svidzinski C. Doxycycline for central centrifugal cicatricial alopecia: A single center retrospective analysis. J Am Acad Dermatol. 2024 Mar 6;. doi: 10.1016/j.jaad.2024.01.086. [Epub ahead of print] PubMed PMID: 38458568.
Agarwal A, Gulati N. Characterizing Occupational Skin Disease Incidence, 2017-2021. Dermatitis. 2024 Mar-Apr;35(2):184-186. doi: 10.1089/derm.2023.0090. Epub 2023 Jun 19. PubMed PMID: 37335944.
Pagan AD, Obi A, McKinley J, Oladunjoye E, Kasago I, Gulati N, Phelps RG, Svidzinski C. Birt-Hogg-Dubé syndrome in skin of color: Literature review. J Am Acad Dermatol. 2024 Feb;90(2):412-414. doi: 10.1016/j.jaad.2023.09.081. Epub 2023 Oct 13. Review. PubMed PMID: 37838258.
Faldetta C, Kaleci S, Chester J, Ruini C, Ciardo S, Manfredini M, Guida S, Chello C, Cantisani C, Young JN, Cabral P, Gulati N, Guttman-Yassky E, Pellacani G, Farnetani F. Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy. J Am Acad Dermatol. 2024 Feb;90(2):309-318. doi: 10.1016/j.jaad.2023.09.084. Epub 2023 Nov 19. PubMed PMID: 37988042.
Poplausky D, Piontkowski AJ, Phelps RG, Gulati N. Microcystic lymphatic malformation following a double mastectomy. JAAD Case Rep. 2024 Feb;44:74-76. doi: 10.1016/j.jdcr.2023.12.011. eCollection 2024 Feb. PubMed PMID: 38304102; PubMed Central PMCID: PMC10831273.
Navrazhina K, Garcet S, Williams SC, Gulati N, Kiecker F, Frew JW, Mitsui H, Krueger JG. Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma. Pigment Cell Melanoma Res. 2024 Jan;37(1):81-89. doi: 10.1111/pcmr.13121. Epub 2023 Sep 30. PubMed PMID: 37776566; PubMed Central PMCID: PMC10841058.
Luu Y, Han J, Agarwal A, Elkady N, Jaroonwanichkul S, Gulati N, Gittler J. Risk for second primary cancers among pediatric and young adult melanoma survivors. Pediatr Dermatol. 2024 Jan-Feb;41(1):12-15. doi: 10.1111/pde.15421. Epub 2023 Sep 29. PubMed PMID: 37776000.
Young JN, Verma H, El Kashlan N, Poplausky D, Lamb AJ, Guttman-Yassky E, Gulati N. The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study. JAAD Case Rep. 2024 Jan;43:1-3. doi: 10.1016/j.jdcr.2023.09.041. eCollection 2024 Jan. PubMed PMID: 38090670; PubMed Central PMCID: PMC10711396.
Young JN, Rivera-Oyola R, Poplausky D, Suemitsu Y, Kim RH, Doroshow D, Gulati N. A case of urticarial vasculitis associated with atezolizumab. JAAD Case Rep. 2024 Jan;43:30-33. doi: 10.1016/j.jdcr.2023.09.042. eCollection 2024 Jan. PubMed PMID: 38162407; PubMed Central PMCID: PMC10757233.

2023

Han J, Dahabreh D, Agarwal A, Luu Y, Kamat S, Golant A, Ungar J, Gulati N. Implementation of a dermatology skin of color educational module for medical students. Dermatol Online J. 2023 Dec 15;29(6). doi: 10.5070/D329662989. PubMed PMID: 38478660.
O’Hagan R, Poplausky D, Young JN, Gulati N, Levoska M, Ungar B, Ungar J. The Accuracy and Appropriateness of ChatGPT Responses on Nonmelanoma Skin Cancer Information Using Zero-Shot Chain of Thought Prompting. JMIR Dermatol. 2023 Dec 14;6:e49889. doi: 10.2196/49889. PubMed PMID: 38096013; PubMed Central PMCID: PMC10755659.
O’Hagan R, Ungar B, Gulati N. Atopic dermatitis increases the risk of mature T/NK-cell lymphomas in a Finnish population: A two-sample Mendelian randomization study. J Eur Acad Dermatol Venereol. 2023 Dec 7;. doi: 10.1111/jdv.19673. [Epub ahead of print] PubMed PMID: 38059414.
Dubin DP, Yassky D, Poplausky D, Young JN, Tan KJ, Gulati N. Dupilumab to Treat Drug Reaction with Eosinophilia and Systemic Symptoms: A Case Series. J Allergy Clin Immunol Pract. 2023 Aug 25;. doi: 10.1016/j.jaip.2023.08.028. [Epub ahead of print] PubMed PMID: 37634806.
Han J, Owji S, Agarwal A, Kamat S, Luu Y, Mubasher A, Niedt G, Ray C, Cho HJ, Gulati N, Lamb A. Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma. Dermatopathology (Basel). 2023 Jul 21;10(3):226-230. doi: 10.3390/dermatopathology10030031. PubMed PMID: 37489455; PubMed Central PMCID: PMC10366922.
Owji S, He H, Han J, Baek P, Yassky D, Gulati N, Ungar B, Ungar J. Use of dynamic optical coherence tomography in a corticosteroid vasoconstrictor assay: a pilot study. Int J Dermatol. 2023 Jul;62(7):e414-e416. doi: 10.1111/ijd.16473. Epub 2022 Nov 1. PubMed PMID: 36318649.
Agarwal A, Gulati N. Characterizing Occupational Skin Disease Incidence, 2017-2021. Dermatitis. 2023 Jun 19;. doi: 10.1089/derm.2023.0090. [Epub ahead of print] PubMed PMID: 37335944.
Han J, Stratman S, Young JN, Poplausky D, Owji S, Luu Y, Estrada Y, Correa da Rosa J, Krueger JG, Gulati N. Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin. J Dermatol. 2023 Jun;50(6):804-809. doi: 10.1111/1346-8138.16688. Epub 2022 Dec 28. PubMed PMID: 36578124.
Pagan AD, Jung S, Caldas S, Ungar J, Gulati N, Ungar B. Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases. J Drugs Dermatol. 2023 Jun 1;22(6):576-581. doi: 10.36849/JDD.7424. PubMed PMID: 37276159.
Poplausky D, Young JN, Tai H, Rivera-Oyola R, Gulati N, Brown RM. Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments. Cancers (Basel). 2023 May 16;15(10). doi: 10.3390/cancers15102770. Review. PubMed PMID: 37345107; PubMed Central PMCID: PMC10216721.
Young JN, Ross O’Hagan, Poplausky D, Levoska MA, Gulati N, Ungar B, Ungar J. The utility of ChatGPT in generating patient-facing and clinical responses for melanoma. J Am Acad Dermatol. 2023 May 18;. doi: 10.1016/j.jaad.2023.05.024. [Epub ahead of print] PubMed PMID: 37207953.
Owji S, Ungar B, Dubin DP, Poplausky D, Young JN, Ghalili S, Han J, Srinivasan D, Packer S, Pavel AB, Correa da Rosa J, Guttman-Yassky E, Gulati N. No association between dupilumab use and short-term cancer development in atopic dermatitis patients. J Allergy Clin Immunol Pract. 2023 May;11(5):1548-1551. doi: 10.1016/j.jaip.2022.12.018. Epub 2022 Dec 26. PubMed PMID: 36581076.
Han J, Baek P, Da Rosa JC, Young JN, Poplausky D, Tai H, Owji S, Ungar B, Gulati N, Ungar J. The pursuit of equity in skin cancer prevention: a survey-based investigation of total body skin exam awareness and utilization across Fitzpatrick skin type. Clin Exp Dermatol. 2023 Apr 27;48(5):540-541. doi: 10.1093/ced/llad009. PubMed PMID: 36702794.
Agarwal A, Patel S, Gulati N. Characterizing dermatologic health needs among Ukrainian forced migrants. J Eur Acad Dermatol Venereol. 2023 Apr 15;. doi: 10.1111/jdv.19114. [Epub ahead of print] PubMed PMID: 37060271.
Han J, Tai H, Poplausky D, Young J, Revankar R, Baek P, Walsh S, Gulati N. Management of lentiginous melanoma with imiquimod assessed by reflectance confocal microscopy. Skin Health Dis. 2023 Apr;3(2):e212. doi: 10.1002/ski2.212. eCollection 2023 Apr. PubMed PMID: 37013121; PubMed Central PMCID: PMC10066750.
Han J, Correa da Rosa J, Agarwal A, Owji S, Yassky D, Luu Y, Shah A, Estrada Y, Ungar J, Sarin KY, Krueger JG, Gulati N. Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy. JID Innov. 2023 Mar;3(2):100179. doi: 10.1016/j.xjidi.2022.100179. eCollection 2023 Mar. PubMed PMID: 36876222; PubMed Central PMCID: PMC9982329.
Han J, Baek P, Poplausky D, Agarwal A, Young JN, Mubasher A, Niedt G, Patel V, Gulati N. A case of lichenoid drug eruption associated with relugolix. JAAD Case Rep. 2023 Mar;33:33-35. doi: 10.1016/j.jdcr.2023.01.003. eCollection 2023 Mar. PubMed PMID: 36843662; PubMed Central PMCID: PMC9946818.
Luu Y, Han J, Owji S, Kamat S, Luu C, Ungar J, Gulati N. Accelerated Healing from Severe Radiation Dermatitis Using Noncontact, Low-frequency Ultrasound-assisted Saline Wash Therapy. Adv Skin Wound Care. 2023 Jan 1;36(1):41-43. doi: 10.1097/01.ASW.0000897440.98255.e5. PubMed PMID: 36537774.

2022

Han J, Agarwal A, Young JN, Owji S, Luu Y, Poplausky D, Yassky D, Estrada Y, Ungar J, Krueger JG, Gulati N. Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment. Sci Rep. 2022 Dec 26;12(1):22364. doi: 10.1038/s41598-022-27020-1. PubMed PMID: 36572780; PubMed Central PMCID: PMC9792448.
Lim Y, Kang SJ, Cho BK, Kim HJ, Mun JH, Roh MR, Gulati N, Yang HJ, Moon JH, Won CH, Park CG. Intra-tumoral heterogeneity and immune escape of melanoma arising from congenital melanocytic nevus revealed by spatial gene expression profiling. J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1044-e1047. doi: 10.1111/jdv.18443. Epub 2022 Aug 3. PubMed PMID: 35857376.
Owji S, Dubin DP, Yassky D, Han J, Tan K, Jagannath S, Parekh S, Gulati N. Dupilumab in Multiple Myeloma: A Case Series. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):928-932. doi: 10.1016/j.clml.2022.09.002. Epub 2022 Sep 20. PubMed PMID: 36243663.
Han J, Correa da Rosa J, Owji S, Yassky D, Luu Y, Estrada Y, Ungar J, Ji A, Krueger JG, Gulati N. Skin proteomic analysis of immune activation associated with regression of melanoma metastases induced by diphencyprone. JAAD Int. 2022 Dec;9:65-68. doi: 10.1016/j.jdin.2022.08.006. eCollection 2022 Dec. PubMed PMID: 36147215; PubMed Central PMCID: PMC9486131.
Diaz A, Tai H, Gulati N. Common warts superinfected with monkeypox. Int J Dermatol. 2022 Nov 13;. doi: 10.1111/ijd.16513. [Epub ahead of print] PubMed PMID: 36371716.
Han J, von Csiky-Sessoms S, Owji S, Yao CJ, Ungar J, Gulati N, Marmur E. Distinct Approaches to Perioperative Management of Anticoagulation and Antiplatelet Therapy among Providers Performing Cutaneous Surgery. J Drugs Dermatol. 2022 Jul 1;21(7):766-772. doi: 10.36849/JDD.6726. PubMed PMID: 35816060.
Han J, Russo G, Stratman S, Psomadakis CE, Rigo R, Owji S, Luu Y, Mubasher A, Gonzalez BR, Ungar J, Harp J, Magro C, Ungar B, Lamb A, Gulati N. Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine. JAAD Case Rep. 2022 Jun;24:101-104. doi: 10.1016/j.jdcr.2022.04.021. Epub 2022 May 7. PubMed PMID: 35571457; PubMed Central PMCID: PMC9077902.
Han J, Kamat S, Agarwal A, O’Hagan R, Tukel C, Owji S, Ghalili S, Luu Y, Dautriche Svidzinski C, Abittan BJ, Ungar J, Gulati N. Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends. JMIR Dermatol. 2022 Apr-Jun;5(2):e37271. doi: 10.2196/37271. eCollection 2022 Apr-Jun. PubMed PMID: 35505684; PubMed Central PMCID: PMC9048188.
Joo EH, Bae JH, Park J, Bang YJ, Han J, Gulati N, Kim JI, Park CG, Park WY, Kim HJ. Deconvolution of Adult T-Cell Leukemia/Lymphoma With Single-Cell RNA-Seq Using Frozen Archived Skin Tissue Reveals New Subset of Cancer-Associated Fibroblast. Front Immunol. 2022;13:856363. doi: 10.3389/fimmu.2022.856363. eCollection 2022. PubMed PMID: 35464471; PubMed Central PMCID: PMC9021607.

2021

Sawyers A, Chou M, Johannet P, Gulati N, Qian Y, Zhong J, Osman I. Clinical outcomes in cancer patients with COVID-19. Cancer Rep (Hoboken). 2021 Dec;4(6):e1413. doi: 10.1002/cnr2.1413. Epub 2021 Aug 19. PubMed PMID: 34409775; PubMed Central PMCID: PMC8420395.
Gulati N, Celen A, Johannet P, Mehnert JM, Weber J, Krogsgaard M, Osman I, Zhong J. Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors. Cancer Med. 2021 Nov;10(21):7457-7465. doi: 10.1002/cam4.4239. Epub 2021 Oct 14. PubMed PMID: 34647433; PubMed Central PMCID: PMC8559502.
Shah P, Gulati N, Stein J, Polsky D, Lee N, Liebman TN. Utility of confocal microscopy in the management of lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 2021 Jun;84(6):1736-1737. doi: 10.1016/j.jaad.2020.08.101. Epub 2020 Aug 29. PubMed PMID: 32871163.
Johannet P, Sawyers A, Gulati N, Donnelly D, Kozloff S, Qian Y, Floristan A, Hernando E, Zhong J, Osman I. Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients. J Transl Med. 2021 Jan 30;19(1):47. doi: 10.1186/s12967-021-02712-w. PubMed PMID: 33516263; PubMed Central PMCID: PMC7847556.

2020

Gulati N, Donnelly D, Qian Y, Moran U, Johannet P, Zhong J, Osman I. Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors. J Transl Med. 2020 Nov 11;18(1):430. doi: 10.1186/s12967-020-02612-5. PubMed PMID: 33176813; PubMed Central PMCID: PMC7659132.
Johannet P, Sawyers A, Qian Y, Kozloff S, Gulati N, Donnelly D, Zhong J, Osman I. Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer. J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001674. PubMed PMID: 33219093; PubMed Central PMCID: PMC7682457.

2019 and Prior

Yan BY, Garcet S, Gulati N, Kiecker F, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M, Shemer A, Mitsui H, Krueger JG. Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin. Exp Dermatol. 2019 Jan;28(1):35-44. doi: 10.1111/exd.13805. Epub 2018 Dec 21. PubMed PMID: 30326165; PubMed Central PMCID: PMC6333525.
Gareau DS, Correa da Rosa J, Yagerman S, Carucci JA, Gulati N, Hueto F, DeFazio JL, Suárez-Fariñas M, Marghoob A, Krueger JG. Digital imaging biomarkers feed machine learning for melanoma screening. Exp Dermatol. 2017 Jul;26(7):615-618. doi: 10.1111/exd.13250. Epub 2016 Dec 19. PubMed PMID: 27783441; PubMed Central PMCID: PMC5516237.
Nirschl CJ, Suárez-Fariñas M, Izar B, Prakadan S, Dannenfelser R, Tirosh I, Liu Y, Zhu Q, Devi KSP, Carroll SL, Chau D, Rezaee M, Kim TG, Huang R, Fuentes-Duculan J, Song-Zhao GX, Gulati N, Lowes MA, King SL, Quintana FJ, Lee YS, Krueger JG, Sarin KY, Yoon CH, Garraway L, Regev A, Shalek AK, Troyanskaya O, Anandasabapathy N. IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Cell. 2017 Jun 29;170(1):127-141.e15. doi: 10.1016/j.cell.2017.06.016. PubMed PMID: 28666115; PubMed Central PMCID: PMC5569303.
Ohmatsu H, Humme D, Gonzalez J, Gulati N, Möbs M, Sterry W, Krueger JG. IL-32 induces indoleamine 2,3-dioxygenase(+)CD1c(+) dendritic cells and indoleamine 2,3-dioxygenase(+)CD163(+) macrophages: Relevance to mycosis fungoides progression. Oncoimmunology. 2017;6(2):e1181237. doi: 10.1080/2162402X.2016.1181237. eCollection 2017. PubMed PMID: 28344860; PubMed Central PMCID: PMC5353917.
Gulati N, Garcet S, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M, Li X, Suárez-Fariñas M, Coit DG, Krueger JG. Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone. J Invest Dermatol. 2016 Oct;136(10):2101-2103. doi: 10.1016/j.jid.2016.06.611. Epub 2016 Jul 1. PubMed PMID: 27377699.
Mitsui H, Kiecker F, Shemer A, Cannizzaro MV, Wang CQF, Gulati N, Ohmatsu H, Shah KR, Gilleaudeau P, Sullivan-Whalen M, Cueto I, McNutt NS, Suárez-Fariñas M, Krueger JG. Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria. J Invest Dermatol. 2016 Oct;136(10):2030-2040. doi: 10.1016/j.jid.2015.11.035. Epub 2016 Jul 1. PubMed PMID: 27377700.
Gulati N, Carvajal RD, Postow MA, Wolchok JD, Krueger JG. Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment. Exp Dermatol. 2016 Jul;25(7):553-4. doi: 10.1111/exd.13030. PubMed PMID: 27061281; PubMed Central PMCID: PMC4927368.
Fuentes-Duculan J, Gulati N, Bonifacio KM, Kunjravia N, Zheng X, Suárez-Fariñas M, Shemer A, Guttman-Yassky E, Krueger JG. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Exp Dermatol. 2016 Apr;25(4):282-6. doi: 10.1111/exd.12918. Epub 2016 Mar 3. PubMed PMID: 26661294.
Gulati N, Løvendorf MB, Zibert JR, Akat KM, Renwick N, Tuschl T, Krueger JG. Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin. Exp Dermatol. 2015 Dec;24(12):953-7. doi: 10.1111/exd.12813. Epub 2015 Aug 27. PubMed PMID: 26205579; PubMed Central PMCID: PMC4701645.
Harden JL, Hamm D, Gulati N, Lowes MA, Krueger JG. Deep Sequencing of the T-cell Receptor Repertoire Demonstrates Polyclonal T-cell Infiltrates in Psoriasis. F1000Res. 2015;4:460. doi: 10.12688/f1000research.6756.1. eCollection 2015. PubMed PMID: 26594339; PubMed Central PMCID: PMC4648215.
Gulati N, Suárez-Fariñas M, Correa da Rosa J, Krueger JG. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149. doi: 10.12688/f1000research.6581.1. eCollection 2015. PubMed PMID: 26236467; PubMed Central PMCID: PMC4505786.
Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, Desmarais C, Robins H, Krueger JG, Clark RA, Kupper TS. Common clonal origin of central and resident memory T cells following skin immunization. Nat Med. 2015 Jun;21(6):647-53. doi: 10.1038/nm.3860. Epub 2015 May 11. PubMed PMID: 25962122; PubMed Central PMCID: PMC4632197.
Belasco J, Louie JS, Gulati N, Wei N, Nograles K, Fuentes-Duculan J, Mitsui H, Suárez-Fariñas M, Krueger JG. Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol. 2015 Apr;67(4):934-44. doi: 10.1002/art.38995. PubMed PMID: 25512250; PubMed Central PMCID: PMC4406155.
Gulati N, Mitsui H, Fuentes-Duculan J, Gonzalez J, Wang CQ, Shah KR, Gilleaudeau P, Sullivan-Whalen M, Kiecker F, McNutt NS, Suárez-Fariñas M, Krueger JG. Dendritic cells are contained within melanocytic nevus nests in vivo and can alter gene expression of epidermal melanocytes in vitro. Pigment Cell Melanoma Res. 2015 Jan;28(1):110-3. doi: 10.1111/pcmr.12324. Epub 2014 Nov 3. PubMed PMID: 25308477; PubMed Central PMCID: PMC8647048.
Wolk K, Mitsui H, Witte K, Gellrich S, Gulati N, Humme D, Witte E, Gonsior M, Beyer M, Kadin ME, Volk HD, Krueger JG, Sterry W, Sabat R. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clin Cancer Res. 2014 Nov 1;20(21):5507-16. doi: 10.1158/1078-0432.CCR-14-0707. Epub 2014 Sep 11. PubMed PMID: 25212608.
Gulati N, Suárez-Fariñas M, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M, Correa da Rosa J, Cueto I, Mitsui H, Krueger JG. Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights. J Invest Dermatol. 2014 Oct;134(10):2531-2540. doi: 10.1038/jid.2014.196. Epub 2014 Apr 21. PubMed PMID: 24751728; PubMed Central PMCID: PMC4165712.
Ohmatsu H, Humme D, Gulati N, Gonzalez J, Möbs M, Suárez-Fariñas M, Cardinale I, Mitsui H, Guttman-Yassky E, Sterry W, Krueger JG. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Cancer Immunol Res. 2014 Sep;2(9):890-900. doi: 10.1158/2326-6066.CIR-13-0199-T. Epub 2014 Jun 17. PubMed PMID: 24938282; PubMed Central PMCID: PMC4346156.
Mitsui H, Suárez-Fariñas M, Gulati N, Shah KR, Cannizzaro MV, Coats I, Felsen D, Krueger JG, Carucci JA. Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7. J Invest Dermatol. 2014 May;134(5):1418-1427. doi: 10.1038/jid.2013.494. Epub 2013 Nov 22. PubMed PMID: 24270662; PubMed Central PMCID: PMC3989465.
Chiricozzi A, Nograles KE, Johnson-Huang LM, Fuentes-Duculan J, Cardinale I, Bonifacio KM, Gulati N, Mitsui H, Guttman-Yassky E, Suárez-Fariñas M, Krueger JG. IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS One. 2014;9(2):e90284. doi: 10.1371/journal.pone.0090284. eCollection 2014. PubMed PMID: 24587313; PubMed Central PMCID: PMC3938679.
Gulati N, Krueger JG, Suárez-Fariñas M, Mitsui H. Creation of differentiation-specific genomic maps of human epidermis through laser capture microdissection. J Invest Dermatol. 2013 Nov;133(11):2640-2642. doi: 10.1038/jid.2013.190. Epub 2013 Apr 18. PubMed PMID: 23677166; PubMed Central PMCID: PMC3766390.
Dhingra N, Gulati N, Guttman-Yassky E. Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis. J Invest Dermatol. 2013 Oct;133(10):2311-2314. doi: 10.1038/jid.2013.239. PubMed PMID: 24030647; PubMed Central PMCID: PMC3773606.
Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T, Gulati N, Fuentes-Duculan J, Suárez-Fariñas M, Lowes MA. TREM-1 as a potential therapeutic target in psoriasis. J Invest Dermatol. 2013 Jul;133(7):1742-51. doi: 10.1038/jid.2013.68. Epub 2013 Feb 13. PubMed PMID: 23407402; PubMed Central PMCID: PMC3697914.
Kennedy Crispin M, Fuentes-Duculan J, Gulati N, Johnson-Huang LM, Lentini T, Sullivan-Whalen M, Gilleaudeau P, Cueto I, Suárez-Fariñas M, Lowes MA, Krueger JG. Gene profiling of narrowband UVB-induced skin injury defines cellular and molecular innate immune responses. J Invest Dermatol. 2013 Mar;133(3):692-701. doi: 10.1038/jid.2012.359. Epub 2012 Nov 15. PubMed PMID: 23151847; PubMed Central PMCID: PMC3679916.
Doan HQ, Gulati N, Levis WR. Ingenol mebutate: potential for further development of cancer immunotherapy. J Drugs Dermatol. 2012 Oct;11(10):1156-7. PubMed PMID: 23134979; PubMed Central PMCID: PMC4283592.
Kennedy-Crispin M, Billick E, Mitsui H, Gulati N, Fujita H, Gilleaudeau P, Sullivan-Whalen M, Johnson-Huang LM, Suárez-Fariñas M, Krueger JG. Human keratinocytes’ response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J Invest Dermatol. 2012 Jan;132(1):105-13. doi: 10.1038/jid.2011.262. Epub 2011 Sep 1. PubMed PMID: 21881590; PubMed Central PMCID: PMC3235229.
Lee DS, Gulati N, Martiniuk F, Levis WR. CD70 and Th17 are involved in human contact sensitivity. J Drugs Dermatol. 2011 Oct;10(10):1192-4. PubMed PMID: 21968671; PubMed Central PMCID: PMC3299413.

Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M, Gilleaudeau P, Cohen JA, Krueger JG. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One. 2011 Apr 25;6(4):e18907. doi: 10.1371/journal.pone.0018907. PubMed PMID: 21541348; PubMed Central PMCID: PMC3081835.
Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Int J Oncol. 2009 Oct;35(4):731-40. doi: 10.3892/ijo_00000386. PubMed PMID: 19724909.
Zohrabian VM, Nandu H, Gulati N, Khitrov G, Zhao C, Mohan A, Demattia J, Braun A, Das K, Murali R, Jhanwar-Uniyal M. Gene expression profiling of metastatic brain cancer. Oncol Rep. 2007 Aug;18(2):321-8. PubMed PMID: 17611651.
Nagpal J, Jamoona A, Gulati ND, Mohan A, Braun A, Murali R, Jhanwar-Uniyal M. Revisiting the role of p53 in primary and secondary glioblastomas. Anticancer Res. 2006 Nov-Dec;26(6C):4633-9. PubMed PMID: 17214319.
Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res. 2006 Mar-Apr;26(2A):1177-81. PubMed PMID: 16619521.